As AstraZeneca floods money into the U.S. market with a wide-ranging investment plan, the company has tapped an in-house ...

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement about lowering U.S. drug prices, at the White House in Washington, ...

Only 40% of new medicines are currently available in Europe, compared with 85% in the United States. AstraZeneca executive, ...

AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...

AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit.